Document:

EX-10.4

  Exhibit 10.4

   

  CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT VIR BIOTECHNOLOGY, INC. TREATS AS PRIVATE OR CONFIDENTIAL.

   

  		
	AMENDMENT INFORMATION

	Agreement to be Amended:
	Grant agreement between the Bill & Melinda Gates Foundation and Vir Biotechnology Inc effective March 16, 2018, as amended, and bearing Investment ID INV-009475/OPP1182112

	Amendment Purpose:
	No Cost Extension 

	Amendment Date:
	Date of this email  

	Amended “End Date”:
	The term of the Agreement is extended by changing the End Date to January 31, 2022

   

  							
	THIS AMENDMENT amends, and is made part of, the above-referenced Agreement and is effective as of the date of this email. Capitalized terms not defined in this Amendment will have the meaning provided in the Agreement. Except as modified by this Amendment, all other terms and conditions of the Agreement remain in full force and effect. In the event of a conflict between the Agreement and this Amendment, the terms of this Amendment will prevail.

	 

	 
UPDATED REPORTING & PAYMENT SCHEDULE

	This Amendment notifies You that the reporting and/or payment schedule for Your grant has changed. Your updated Reporting & Payment Schedule is deleted and replaced with the following: 

	 

	REPORTING & PAYMENT SCHEDULE 
	 

	[***]
	[***]
	[***]
	[***]
	[***]
	 

	 
	[***]
	[***]
	[***]
	[***]
	 

	[***]
	[***]
	[***]
	[***]
	[***]
	 

	 
	[***]
	[***]
	[***]
	[***]
	 

	[***]
	[***]
	[***]
	 
	 
	 

	[***]
	[***]
	[***]
	 
	 
	 

	 
	[***]
	 
	[***]
	[***]
	 

	[***]
	[***]
	[***]
	 
	 
	 

	Total Grant Amount 
	Up to $14,882,418.08Document

EXHIBIT 10.1

SIXTH AMENDMENT TO NOTE PURCHASE AGREEMENT

THIS SIXTH AMENDMENT TO NOTE PURCHASE AGREEMENT (this “Sixth Amendment”) is entered into as of August 3, 2021 by and among ONTRAK, INC., a Delaware corporation formerly known as CATASYS, INC. (the “Company”), the Purchaser signatory hereto and GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., as collateral agent for the Purchasers (in such capacity, the “Collateral Agent”).

RECITALS

A.     The Company, certain subsidiaries of the Company, the Purchaser and the Collateral Agent are parties to a certain Note Purchase Agreement, dated as of September 24, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Note Purchase Agreement”; capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Note Purchase Agreement), pursuant to which the Purchaser has agreed to purchase the Notes issued by Company; 
B.    The Company has requested an amendment to the Note Purchase Agreement to adjust certain financial covenants set forth therein and, subject to the terms and conditions hereof, the Purchaser (being the sole Purchaser under the Note Purchase Agreement) executing this Sixth Amendment is willing to do so; 
NOW, THEREFORE, in consideration of the premises and the mutual covenants hereinafter contained, and intending to be legally bound, the parties hereto agree as follows:

A.  AMENDMENTS

1.Section 1.1 of the Note Purchase Agreement is hereby amended by replacing the defined term “Leverage Changeover Date” in its entirety with the following:
“‘Leverage Changeover Date’ means the date corresponding to the earlier of (i) September 30, 2023 or (ii) the date on which Company and its Subsidiaries have delivered Compliance Certificates under Section 5.1(d) evidencing a Leverage Ratio (calculated based on Consolidated Adjusted EBITDA) less than or equal to 6.00:1.00.”
2.Section 6.8 of the Note Purchase Agreement is hereby amended by replacing clause (b) thereof in its entirety with the following:
“(b)     Fixed Charge Coverage Ratio.  Following the Leverage Changeover Date, Company shall not permit the Fixed Charge Coverage Ratio as of the last day of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30, 2023, to be less than the correlative ratio indicated below:

						
	Fiscal Quarter End Date	Fixed Charge Coverage Ratio
	September 30, 2023	1.50:1.00
	December 31, 2023 until the Maturity Date	2.00:1.00

3.Section 6.8 of the Note Purchase Agreement is hereby amended by replacing clause (c) thereof in its entirety with the following:
“(c)     Leverage Ratio.
(i)Prior to the Leverage Changeover Date, Company shall not permit the Leverage Ratio as of the last day of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30, 2019, to be greater than the correlative ratio indicated below:
						
	Fiscal Quarter End Date	Leverage 
Ratio
	September 30, 2019	1.20:1.00
	December 31, 2019	1.20:1.00
	March 31, 2020	1.20:1.00
	June 30, 2020	0.75:1.00
	September 30, 2020	0.75:1.00
	December 31, 2020	0.75:1.00
	March 31, 2021	0.50:1.00
	June 30, 2021	0.60:1.00
	September 30, 2021	0.65:1.00
	December 31, 2021	0.85:1.00
	March 31, 2022	1.00:1.00
	June 30, 2022	0.90:1.00
	September 30, 2022	0.75:1.00
	December 31, 2022	0.60:1.00
	March 31, 2023	0.55:1.00
	June 30, 2023	0.50:1.00

(ii)On or after the Leverage Changeover Date, Company shall not permit the Leverage Ratio as of the last day of any Fiscal Quarter, to be greater than the correlative ratio indicated below:
2

						
	Fiscal Quarter End Date	Leverage 
Ratio
	On or after the Leverage Change Over Date but prior to September 30, 2023	6.00:1.00
	September 30, 2023	5.00:1.00
	December 31, 2023	4.00:1.00
	March 31, 2024	3.00:1.00
	June 30, 2024	3.00:1.00
	September 30, 2024	3.00:1.00

  
4.Section 6.8 of the Note Purchase Agreement is hereby amended by replacing clause (d) thereof in its entirety with the following:
“(d)    Consolidated Adjusted EBITDA.  Company shall not permit Consolidated Adjusted EBITDA as at the end of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30, 2019, for the four Fiscal Quarter period then ended to be less than the correlative amount indicated below:
3

						
	Fiscal Quarter	Consolidated
Adjusted EBITDA
	September 30, 2019	-$17,250,000
	December 31, 2019	-$24,000,000
	March 31, 2020	-$28,500,000
	June 30, 2020	-$23,750,000
	September 30, 2020	-$16,500,000
	December 31, 2020	-$7,750,000
	March 31, 2021	$0
	June 30, 2021	$0
	September 30, 2021	-$10,000,000
	December 31, 2021	-$22,000,000
	March 31, 2022	-$32,500,000
	June 30, 2022	-$32,500,000
	September 30, 2022	-$25,000,000
	December 31, 2022	-$13,000,000
	March 31, 2023	-$5,000,000
	June 30, 2023	$2,000,000
	September 30, 2023	$10,000,000
	December 31, 2023	$18,500,000
	March 31, 2024	$20,000,000
	June 30, 2024	$20,000,000
	September 30, 2024	$20,000,000

For the purposes of determining compliance with the covenant set forth in this Section 6.8(d) following consummation of a Permitted Acquisition each of the minimum Consolidated Adjusted EBITDA amounts set forth in this Section 6.8(d), following the consummation date, shall be increased by 100% of Consolidated Adjusted EBITDA of the entity or assets being acquired for the four Fiscal Quarter period most recently ended prior to the consummation of such Permitted Acquisition.”
5.Section 6.8 of the Note Purchase Agreement is hereby amended by replacing clause (h) thereof in its entirety with the following:
“(h)    Minimum Consolidated Liquidity. Company shall not permit Consolidated Liquidity at the end of any Fiscal Quarter to be less than the correlative amount indicated below:
4

						
	Fiscal Quarter	Consolidated
Liquidity
	June 30, 2021	$85,000,000
	September 30, 2021	$65,000,000
	December 31, 2021	$50,000,000
	March 31, 2022	$40,000,000
	June 30, 2022	$30,000,000
	September 30, 2022	$30,000,000
	December 31, 2022	$30,000,000
	March 31, 2023	$25,000,000
	June 30, 2023	$25,000,000
	September 30, 2023	$25,000,000
	December 31, 2023	$25,000,000
	March 31, 2024	$25,000,000
	June 30, 2024	$25,000,000
	September 30, 2024	$25,000,000

6.Section 6.8 of the Note Purchase Agreement is hereby amended by deleting clause (i) thereof in its entirety. 
C.  CONDITIONS TO EFFECTIVENESS 

Notwithstanding any other provision of this Sixth Amendment and without affecting in any manner the rights of the Purchaser hereunder, it is understood and agreed that this Sixth Amendment shall not become effective, and the Note Parties shall have no rights under this Sixth Amendment, until the Purchaser shall have received (i) an executed amended and restated Fee Letter from the Company and the Purchaser and (ii) executed counterparts to this Sixth Amendment from the Company and the Purchaser.

D.   REPRESENTATIONS

To induce the Purchaser and the Collateral Agent to enter into this Sixth Amendment, each Note Party hereby represents and warrants to the Purchaser and the Collateral Agent that: 

1.    Each of the Note Parties and its Subsidiaries (a) is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, (b) has all requisite power and authority to own and operate its properties, to carry on its business as now conducted and as proposed to be conducted, to enter into the Note Documents to which it is a party and to carry out the transactions contemplated thereby, and (c) is qualified to do business and in good standing in every jurisdiction where its assets are located and wherever necessary to carry out its business and operations, except in jurisdictions where the failure to be so qualified or in good 
5

standing has not had, and could not be reasonably expected to have, a Material Adverse Effect; and 

2.    The execution, delivery and performance of this Sixth Amendment has been duly authorized by all necessary action on the part of each Note Party that is a party hereto.

E.  OTHER AGREEMENTS

1.    Continuing Effectiveness of Note Documents.  As amended hereby, all terms of the Note Purchase Agreement and the other Note Documents shall be and remain in full force and effect and shall constitute the legal, valid, binding and enforceable obligations of the Note Parties party thereto.  To the extent any terms and conditions in any of the other Note Documents shall contradict or be in conflict with any terms or conditions of the Note Purchase Agreement, after giving effect to this Sixth Amendment, such terms and conditions are hereby deemed modified and amended accordingly to reflect the terms and conditions of the Note Purchase Agreement as modified and amended hereby. Upon the effectiveness of this Sixth Amendment such terms and conditions are hereby deemed modified and amended accordingly to reflect the terms and conditions of the Note Purchase Agreement as modified and amended hereby.

2.    [Reserved].  

3.    Acknowledgment of Perfection of Security Interest. Each Note Party hereby acknowledges that, as of the date hereof, the security interests and liens granted to Collateral Agent and the Purchasers under the Note Purchase Agreement and the other Note Documents are in full force and effect, are properly perfected and are enforceable in accordance with the terms of the Note Purchase Agreement and the other Note Documents.

4.    Effect of Agreement.  Except as set forth expressly herein, all terms of the Note Purchase Agreement, as amended hereby, and the other Note Documents shall be and remain in full force and effect and shall constitute the legal, valid, binding and enforceable obligations of the Note Parties to the Purchasers and Collateral Agent.  The execution, delivery and effectiveness of this Sixth Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of the Purchasers under the Note Purchase Agreement, nor constitute a waiver of any provision of the Note Purchase Agreement.  This Sixth Amendment shall constitute a Note Document for all purposes of the Note Purchase Agreement.

5.    Governing Law.   This Sixth Amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York and all applicable federal laws of the United States of America.

6.    No Novation.  This Sixth Amendment is not intended by the parties to be, and shall not be construed to be, a novation of the Note Purchase Agreement and the other Note Documents or an accord and satisfaction in regard thereto.
6

7.    Costs and Expenses.  The Note Parties agree to pay on demand all costs and expenses of Purchaser and Collateral Agent in connection with the preparation, execution and delivery of this Sixth Amendment, including, without limitation, the reasonable fees and out-of-pocket expenses of outside counsel for Purchaser and Collateral Agent with respect thereto.

8.    Counterparts.  This Sixth Amendment may be executed by one or more of the parties hereto in any number of separate counterparts, each of which shall be deemed an original and all of which, taken together, shall be deemed to constitute one and the same instrument.  Delivery of an executed counterpart of this Sixth Amendment by facsimile transmission, electronic transmission (including delivery of an executed counterpart in .pdf format) shall be as effective as delivery of a manually executed counterpart hereof.

9.    Binding Nature.  This Sixth Amendment shall be binding upon and inure to the benefit of the parties hereto, their respective successors, successors-in-titles, and assigns.  No third party beneficiaries are intended in connection with this Sixth Amendment.

10.    Entire Understanding.  This Sixth Amendment sets forth the entire understanding of the parties with respect to the matters set forth herein, and shall supersede any prior negotiations or agreements, whether written or oral, with respect thereto.

11.    Release.  (a) Each Note Party hereby releases, acquits, and forever discharges Collateral Agent and each of the Purchasers, and each and every past and present subsidiary, affiliate, stockholder, officer, director, agent, servant, employee, representative, and attorney of Collateral Agent and the Purchasers (each a “Releasee”), from any and all claims, causes of action, suits, debts, liens, obligations, liabilities, demands, losses, costs and expenses (including attorneys' fees) of any kind, character, or nature whatsoever, known or unknown, fixed or contingent, which such Note Party may have or claim to have now or which may hereafter arise out of or connected with any act of commission or omission of Releasee existing or occurring on or prior to the date of this Sixth Amendment or any instrument executed on or prior to the date of this Sixth Amendment including, without limitation, any claims, liabilities or obligations arising with respect to the Note Purchase Agreement or the other of the Note Documents.  The provisions of this paragraph shall be binding upon each Note Party and shall inure to the benefit of Releasees, and their respective heirs, executors, administrators, successors and assigns, and the other released parties set forth herein.  No Note Party is aware of any claim or offset against, or defense or counterclaim to, any Note Party’s obligations or liabilities under the Note Purchase Agreement or any other Note Document.  The provisions of this Section shall survive payment in full of the Obligations, full performance of the terms of this Sixth Amendment and the Note Documents, and/or Collateral Agent’s or each Purchaser’s actions to exercise any remedy available under the Note Documents or otherwise.  Each Note Party warrants and represents that such Note Party is the sole and lawful owner of all right, title and interest in and to all of the claims released hereby and each Note Party has not heretofore voluntarily, by operation of law or otherwise, assigned or transferred or purported to assign or transfer to any person any such claim or any portion thereof.

7

[remainder of page intentionally left blank]

8

IN WITNESS WHEREOF, this Sixth Amendment has been duly executed as of the date first written above.

ONTRAK, INC., as the Company and as a Note Party 

By: /s/ Brandon LaVerne______________________
Name: Brandon LaVerne
Title:   Chief Financial Officer 

[Signature Page to Sixth Amendment to Note Purchase Agreement]

GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P. as Purchaser 

By: /s/ Gregg Watts                
Name: Gregg Watts
Title: Authorized Signatory

GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P. as Collateral Agent

By: /s/ Gregg Watts                
Name: Gregg Watts
Title: Authorized Signatory

[Signature Page to Sixth Amendment to Note Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]